| MCP | maximum closure pressure; maximum contraction pattern; malanocortin receptor; melphalan, cyclophosph... |
|---|---|
| SCP | single-celled protein; standard care plan; sodium cellulose phosphate; soluble cytoplasmic protein; ... |
| TP | temperature and pressure; temperature probe; temporal peak; temporoparietal; tension pneumothorax; t... |
| TSP | testis-specific protein; thrombin-sensitive protein; thrombospondin; total serum protein; total susp... |
| BLM | bilayer lipid membrane; bimolecular liquid membrane; bleomycin; buccolinguomasticatory |
| Ornish reversal diet | A diet designed by Dean Ornish, who has evidence that it will reverse coronary artery disease. It consists of 10% of calories from fat (mostly polyunsaturated or monounsaturated, with 5 mg cholesterol per day), 70 to 75% from carbohydrate, and 15 to 20% from protein. (05 Mar 2000) |
|---|---|
| elimination diet | A diet designed to detect what ingredient of the food causes allergic manifestations in the patient; food items to which the patient may be sensitive are withdrawn separately and successively from the diet until that which causes the symptoms is discovered. (05 Mar 2000) |
| Kempner diet | A diet of rice, fruit, and sugar, plus vitamin and iron supplements, devised by Kempner to treat hypertension. In 2,000 calories, the diet contains 5 gm or less of fat, about 20 gm of protein, and not more than 150 mg of sodium. Synonym: Kempner diet. (05 Mar 2000) |
| ketogenic diet | A high-fat, low-carbohydrate, and normal protein diet causing ketosis. (05 Mar 2000) |
| liver diet | A special diet for those with liver disease should be low in protein and higher in carbohydrates. (27 Sep 1997) |
| low-calorie diet | A diet of 1,200 calories or less per day. (05 Mar 2000) |
| low-fat diet | A diet containing minimal amounts of fat.Diets containing low amounts of fat and cholesterol are designed to reduce the risk of heart disease and, in some cases, cancer. Dozens of such diets have been promulgated, both by medical and lay advisors. Their popularity can be attributed in part to clinical studies that have, since the 1980s, revealed, on the one hand, the hazards of eating high-fat, high-cholesterol foods and, on the other, the benefits of ingesting less saturated fat and LDL (low density lipoprotein) cholesterol. Although coronary deaths have been reduced by roughly 30% since 1970, the aim of health officials is to further reduce heart attack rates. The average cholesterol level among adult Americans has fallen from 213 to 205 mg/dl since 1978. However, the National Cholesterol Education Program recommends that individuals maintain a total cholesterol level of no more than 200 mg/dl, with LDL at less than 130 mg/dl and HDL (high density lipoprotein) around 60 mg/dl. About one-half of American adults exceed those recommendations. Low-fat, low-cholesterol diets are rich in whole grains, fresh fruits and vegetables, and legumes, and limit or exclude consumption of processed oils, dairy products, nuts and seeds, and meats. See atherosclerosis, free radicals. (05 Mar 2000) |
| low purine diet | A diet low in precursors of purines (such as tissues rich in cells with abundant nuclei, as in liver, glandular meats, etc.) to minimise formation of uric acid. Useful in treatment of patients with gout or urate-containing renal calculi. (05 Mar 2000) |
| low residue diet | A diet that leaves minimal unabsorbed components in the intestine, to minimise functional stress on the colon. (05 Mar 2000) |
| low salt diet | A diet with restricted amounts of sodium chloride, necessary in the treatment of some cases of hypertension, heart failure, and other syndromes characterised by fluid retention and/or oedema formation. (05 Mar 2000) |
| acetoacetyl-acyl carrier protein synthase | <enzyme> E coli enzyme, that catalyses condensation of malonyl-acyl carrier protein plus acetyl-acyl carrier protein; not inhibited by cerulenin Registry number: EC 2.3.1.- Synonym: acetoacetyl-acp synthase (26 Jun 1999) |
| acid soluble spore protein | <molecular biology> A DNA binding protein in the spores of some bacteria, thought to stabilise the DNA in an A configuration, so protecting it from cleavage by enzymes or UV light. (18 Nov 1997) |
| acute-phase protein | <haematology> These plasma proteins (in addition to fibrinogen) increase 25% or more in response to inflammation and injury are under direct control of interleukin-6 (IL-6) (hepatocyte-stimulating factor). Other proteins which increase are ceruloplasmin, C3 and C4 which increase 50% or more; alpha-1 acid glycoprotein, alpha-1 antitrypsin, haptoglobin and fibrinogen (the major determinant of viscosity 1 ) which increase two- to fourfold; C-reactive protein (CRP) and serum amyloid A which increase several hundred-fold. Despite long-held clinical opinion to the contrary, available data indicate that neither ESR nor measurement of specific acute-phase reactants are useful in excluding underlying infection or inflammation regardless of the pretest probability. These proteins are secreted into the blood in increased or decreased quantities by hepatocytes in response to trauma, inflammation, or disease. They can serve as inhibitors or mediators of the inflammatory processes. Certain acute-phase proteins have been used to diagnose and follow the course of diseases or as tumour markers. See also: amyloid, c-reactive protein, erythrocyte sedimentation rate, viscosity. (25 Jun 1999) |
| acyl-(acyl-carrier-protein)-phospholipid acyltransferase | <enzyme> Catalyses the formation of phosphatidylethanolamine from acyl-acyl carrier protein and 2-acyl-sn-glycero-3-phosphoethanolamine Registry number: EC 2.3.1.40 Synonym: 2-acyl-gpe acyltransferase, 2-acylglycerophosphoethanolamine acyltransferase (26 Jun 1999) |
| acyl-(acyl-carrier-protein)-UDP-N-acetylglucosamine acyltransferase | <enzyme> E coli enzyme involved in lipid a biosynthesis; uses beta-hydroxymyristoyl-acyl carrier protein to form udp-3-monoacyl-n-acetylglucosamine; amino acid sequence given in second source Registry number: EC 2.3.1.129 Synonym: udp-aguatransferase, lpxa protein, udp-n-acetylglucosamine-3-acyltransferase, udp-n-acetylglucosamine 3-o-acyltransferase, udp-3-o-(r-3-hydroxymyristoyl)glucosamine-n-acyltransferase, lpxd protein, fira gene product, fira protein (26 Jun 1999) |